Cardiff Oncology | 8-K: Cardiff Oncology Reports First Quarter 2024 Results and Provides Business Update
May 2 16:17 ET
Cardiff Oncology | 10-Q: Quarterly report
May 2 16:05 ET
Cardiff Oncology | DEFA14A: Others
Apr 25 16:17 ET
Cardiff Oncology | ARS: Annual Report to Security Holders
Apr 25 16:15 ET
Cardiff Oncology | DEF 14A: Definitive information statements
Apr 25 16:08 ET
Cardiff Oncology | 8-K: Current report
Apr 8 16:09 ET
Cardiff Oncology | S-8: Initial registration statement for securities to be offered to employees pursuant to employee benefit plans
Mar 27 16:06 ET
Cardiff Oncology | 4: Statement of changes in beneficial ownership of securities-Officer Levine James E.
Mar 7 18:45 ET
Cardiff Oncology | 4: Statement of changes in beneficial ownership of securities-Officer Kabbinavar Fairooz
Mar 7 18:40 ET
Cardiff Oncology | 4: Statement of changes in beneficial ownership of securities-Officer Smeal Tod
Mar 7 18:40 ET
Cardiff Oncology | 4: Statement of changes in beneficial ownership of securities-Officer Erlander Mark
Mar 7 18:40 ET
Cardiff Oncology | 8-K: Cardiff Oncology Reports Fourth Quarter and Full Year 2023 Results and Provides Business Update
Feb 29 16:28 ET
Cardiff Oncology | 10-K: Annual report
Feb 29 16:04 ET
Cardiff Oncology | SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-Acorn Bioventures, L.P.(4.20%),Acorn Capital Advisors GP, LLC(4.20%), etc.
Feb 6 16:03 ET
Cardiff Oncology | 8-K: Current report
Jan 8 00:00 ET
Cardiff Oncology | 4: Statement of changes in beneficial ownership of securities-Director PACE GARY W
Dec 19, 2023 18:39 ET
Cardiff Oncology | 4: Statement of changes in beneficial ownership of securities-Director PACE GARY W
Nov 14, 2023 16:24 ET
Cardiff Oncology | 8-K: Cardiff Oncology Reports Third Quarter 2023 Results and Provides Business Update
Nov 2, 2023 16:06 ET
Cardiff Oncology | 10-Q: Q3 2023 Earnings Report
Nov 2, 2023 16:02 ET
Cardiff Oncology | 8-K: Current report
Sep 26, 2023 16:07 ET
No Data
No Data